- Kratom Effects
- November 11, 2019
Kratom, a popular herbal supplement made from Mitragyna speciosa, an evergreen tree native to Southeast Asia, may cause liver damage, according to new preliminary findings.
Some consumers use kratom to reduce fatigue, boost their energy or provide pain relief. It also sometimes is used to help with opioid withdrawal.
While kratom acts like a stimulant at low doses, researchers said it acts like an opioid when taken in large amounts, according to U.S. News & World Report. They said kratom has been linked to more than 90 deaths.
The researchers presented their findings Saturday at the meeting of the American Association for the Study of Liver Diseases held in Boston.… Continue reading.READ MORE
- Kratom News
- November 11, 2019
BOSTON — A small, but growing number of cases of liver injury, related to the herbal product kratom, have been observed over the past 2 years, a researcher said here.
Cases of kratom-associated hepatotoxicity had been sporadic until 2017, when there were three cases alone for a total of seven cases since 2007, as well as four more pending from 2018, reported Victor Navarro, MD, of Albert Einstein Healthcare Network in Philadelphia.
“This is a bellwether,” he said at a press conference at the Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. “Not only are we seeing increased use of kratom and adverse events associated with it, but liver injury.”
Kratom is derived from an Asian plant, and the authors noted that product has opioid-like effects — a stimulant at low doses and a sedative hypnotic at high doses.… Continue reading.READ MORE
- Kratom Products
- November 10, 2019
FRIDAY, Nov. 8, 2019 (HealthDay News) — Liver injury episodes due to kratom (Mitragyna speciosa) are increasing in the United States, and chemical analysis can confirm the presence of this botanical in herbal and dietary supplements linked to cases of severe liver injury, according to a case series study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases, held from Nov. 8 to 12 in Boston.
Victor J. Navarro, M.D., from the Albert Einstein Healthcare Network in Philadelphia, and colleagues sought to describe kratom-associated hepatotoxicity with chemical analysis to confirm the presence of Mitragyna.… Continue reading.READ MORE